How a Biotech Manufacturing Startup Scaled from Prototype to Production-Ready Operations with Scispot alt-LIMS

Challenges

The startup struggled with inefficient, manual management processes that hindered their ability to scale:

• Manual BOM Management: Reliance on Excel for tracking Bills of Materials (BOM) made it impossible to support complex supply chain planning or evaluate build readiness against material availability.

• Inconsistent Protocols: A lack of standardized formulation templates and version control compromised reproducibility and hindered preparation for FDA regulatory documentation.

• Non-Systematic Planning: The startup lacked the capability to perform systematic production planning, such as backward assessment of capacity based on current inventory.

Solution

Scispot provided an integrated, GMP-compliant alt-LIMS platform to automate and standardize operations:

• Advanced Materials Management: Deployed a materials tracking system that automated BOM assessment, inventory thresholding, and build readiness evaluations against production schedules.

• Standardized Formulation Protocols: Established a formulation template library featuring version control, automated workflow triggers, specification ranges, and Quality Control (QC) checkpoints to ensure consistency.

• Data Infrastructure: Implemented a production-ready data infrastructure featuring built-in audit trails to support regulatory requirements.

Impact

The implementation led to significant improvements in efficiency and accuracy:

• Manual Materials Planning: Achieved an 85% reduction through automated BOM assessment and inventory tracking, which replaced manual Excel-based processes.

• Build Readiness Accuracy: Real-time inventory visibility and automated threshold alerts resulted in a 73% improvement in forecast accuracy.

• Protocol Standardization: Experienced a 90% faster protocol standardization process by utilizing template-based formulation workflows and version control.

‍